Press Offices

Press Offices

SMC Spain amplifies the voices of experts on current topics that provoke controversy. 

¿Qué me ofrece?

The sources that collaborate with SMC Spain will multiply their national and international media impact. Register your office to become part of a directory on this website that journalists can consult. Our guides on communication and science can help you in your daily work.

Icono
Cómo trabajamos

We will rely on you when we contact sources from your organization or when we organize briefing sessions with them. We will provide you with support resources to facilitate your work. You can learn more about our method here

Título qué me ofrece
What We Offer You
Título cómo trabajamos
How We Work

Reactions: WHO recommends immediate skin-to-skin contact instead of incubator for premature and low birth weight infants

The World Health Organisation (WHO) has issued a statement recommending skin-to-skin contact immediately after birth to improve the survival of premature and low birth weight babies. Until now, in clinical practice it was common for the first phase after birth to take place in the incubator.

0

Reactions to the results of the Global Carbon Budget 2022 report

The Global Carbon Project (GCP) today releases its Global Carbon Budget 2022 report. The main conclusion is that there is no sign of a decrease in global CO2 emissions and, at current levels, there is a 50 % chance of exceeding 1.5°C warming in nine years. The results will be published in the journal Earth System Science Data.

0

Reaction to study concluding that global covid-19 incidence is higher than reported

An international team with WHO participation concludes that global covid-19 infection rates may be higher than reported. The research, published in the journal PLOS Medicine, is based on a systematic review and meta-analysis of seroprevalence studies published between 1 January 2020 and 20 May 2022.

0

Reactions to clinical trial using CRISPR to modify patient's own T lymphocytes for cancer treatment

A pioneering phase 1 clinical trial has tested a type of cancer immunotherapy. Researchers have modified patients' own T-lymphocyte receptors using the CRISPR tool to direct them against specific targets on their own tumours. The results are published in the journal Nature.

0

Reaction to the study finding prion forms in the brains of people with dementia and Down syndrome

People with Down syndrome are at high risk of developing dementia very similar to that caused by Alzheimer's disease. A study published in the journal PNAS has found that in these people, as had been observed in "classic" Alzheimer's, the characteristic proteins of the disease have prion-like features.

0